Cargando…
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?
Autores principales: | Ciavarella, Alessandro, Peyvandi, Flora, Martinelli, Ida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169902/ https://www.ncbi.nlm.nih.gov/pubmed/32361513 http://dx.doi.org/10.1016/j.thromres.2020.04.023 |
Ejemplares similares
-
Chloroquine and COVID-19, where do we stand?()
por: Lecuit, M.
Publicado: (2020) -
Addictive behaviors: where do we stand, and where are we going?
por: Thibaut, Florence, et al.
Publicado: (2017) -
The Battle Against COVID-19: Where Do We Stand Now?
por: Negahdaripour, Manica
Publicado: (2020) -
COVID-19 after 18 months: Where do we stand?
por: Chassagnon, Guillaume, et al.
Publicado: (2021) -
Biomarkers for Alzheimer’s Disease: Where Do We Stand and Where Are We Going?
por: Villa, Chiara
Publicado: (2020)